Champions Oncology, Inc. - Common Stock (NQ:CSBR)

4.790 +0.030 (+0.63%)

Delayed Quote Updated: 3:59 PM EST, Nov 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Champions Oncology Announces $5M Stock Repurchase Program

April 05, 2023

Via ACCESSWIRE

$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying ↗

March 22, 2023

The Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Champions Oncology Reports Quarterly Revenue of $12.8 Million

March 15, 2023

Via ACCESSWIRE

Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023

March 13, 2023

Via ACCESSWIRE

Analyzing Champions Oncology's Short Interest ↗

December 15, 2022

Champions Oncology's (NASDAQ:CSBR) short percent of float has risen 6.9% since its last report. The company recently reported that it has 64 thousand shares sold short, which is 0.93% of all regular...

Via Benzinga

Champions Oncology Reports Quarterly Revenue of $12.9 Million

July 21, 2022

Via ACCESSWIRE

Earnings Scheduled For March 15, 2023 ↗

March 15, 2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

Via Benzinga

Champions Oncology's Earnings: A Preview ↗

March 14, 2023

Via Benzinga

Champions Oncology's Return On Capital Employed Insights ↗

December 30, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 15, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 14, 2022

Via Benzinga

Champions Oncology Reports Record Quarterly Revenue of $14.3 Million

December 13, 2022

Via ACCESSWIRE

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022

December 09, 2022

Via ACCESSWIRE

Champions Oncology Reports Record Quarterly Revenue of $13.7 Million

September 08, 2022

Via ACCESSWIRE

Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday ↗

September 16, 2022

Gainers

Via Benzinga

Earnings Scheduled For September 8, 2022 ↗

September 08, 2022

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its second quarter. • Sono Group (NASDAQ:SEV) is estimated to report earnings for its second...

Via Benzinga

Earnings Preview For Champions Oncology ↗

September 07, 2022

Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022

September 06, 2022

Via ACCESSWIRE

Champions Oncology Reports Quarterly Revenue of $12.9 Million

July 21, 2022

Record Annual Revenue of $49.1 Million

From Champions Oncology, Inc.

Via AccessWire

A Preview Of Champions Oncology's Earnings ↗

July 20, 2022

Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022

July 14, 2022

HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...

From Champions Oncology, Inc.

Via AccessWire

Earnings Scheduled For July 21, 2022 ↗

July 21, 2022

Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion.

Via Benzinga

Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics

May 31, 2022

HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative...

From Champions Oncology, Inc.

Via AccessWire

Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo

May 03, 2022

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

From Champions Oncology, Inc.

Via AccessWire

Topics Artificial Intelligence

Here's How Much You Would Have Made Owning Champions Oncology Stock In The Last 5 Years ↗

March 21, 2022

Champions Oncology (NASDAQ:CSBR) has outperformed the market over the past 5 years by 7.88% on an annualized basis. Buying $1,000 In CSBR: 5 years ago, an investor could have...

Via Benzinga

Champions Oncology Earnings Perspective: Return On Capital Employed ↗

March 16, 2022

According to Benzinga Pro, during Q3, Champions Oncology (NASDAQ:CSBR) earned $787.00 thousand, a 184.12% increase from the preceding quarter. Champions Oncology also posted a...

Via Benzinga

Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million

March 15, 2022

HACKENSACK, NJ / ACCESSWIRE / March 15, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...

From Champions Oncology, Inc.

Via AccessWire

Earnings Scheduled For March 15, 2022 ↗

March 15, 2022

Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...

Via Benzinga

Earnings Preview For Champions Oncology ↗

March 14, 2022

Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022

March 11, 2022

HACKENSACK, NJ / ACCESSWIRE / March 11, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...

From Champions Oncology, Inc.

Via AccessWire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.